At the heart of COPD: Exploring cardiopulmonary risk & Smoking Cessation

JW Marriott Gold Coast Resort & Spa

158 Ferny Avenue

Surfers Paradise, QLD(AUS) 4217

Australia

19 August 2025

6:15 pm-8:30 pm AEST

Sorry! This page doesn't exist anymore

Interested in attending our upcoming events? Reach out to us to get more information.

During this educational meeting AstraZeneca products may be discussed. This meeting has been initiated, organised and funded by AstraZeneca. The content is intended for registered HealthCare Professionals for educational purposes. The company seeks no commitment from external stakeholders to take any action as a result of the invitation or related support. In accordance with Medicines Australia Code of Conduct for the Australian prescription medicines industry any costs (eg, travel or meals) incurred by a partner/spouse, guest or family member travelling with a healthcare professional, will not be paid for or subsidised by the company.

HEALTH & SAFETY: AstraZeneca values your health and safety. We choose to use venues and suppliers who have COVID-Safe protocols in place. There will be access to hand sanitiser, tissues and face masks should you need/wish to use these. If you are unwell, tested positive for, or have any known symptoms, of COVID-19 in the last 5-7 days, please stay home.

Pharmacovigilance (PV) activities: AstraZeneca continually monitor the safety profile of their products. To support this ongoing process, and to adhere with local and global regulatory obligations, we must collect all reports of potential Adverse Events (AE), special situations, and product quality complaints, in relation to a patient potentially administered an AstraZeneca product. If we identify a potential report during our communications with you, this will be shared with AstraZeneca’s medical (pharmacovigilance) team. The information may be disclosed to local and overseas regulatory authorities or other third parties (such as those providing AE case processing activities, or license partners), for the purposes of meeting pharmacovigilance requirements. If you provide your contact details to us, you consent to us using those details to contact you for further information on the AE reports.

PRIVACY STATEMENT: Your personal information ("Information") will be collected and used by AstraZeneca Pty Ltd (ABN 54 009 682 311) ("AstraZeneca") to register you for this event, for follow-up purposes and for any other purpose described in AstraZeneca's Privacy Policy (see below for link). AstraZeneca may collect your Information from third parties such as travel agents to organise travel arrangements for an event. AstraZeneca may disclose your Information to our related entities or service providers (including IT support/service providers), some of which may be located overseas including in the US, European Union and Asia Pacific. If you do not provide your Information, AstraZeneca will not be able to register you for this event. Please refer to our Privacy Policy at http://www.astrazeneca.com.au/privacy-policy for more information about how your Information is handled and how you may seek to access or correct your Information, or submit a privacy complaint. AstraZeneca's address is 66 Talavera Road, Macquarie Park, NSW, 2113.

BREZTRI AEROSPHERE^® is a registered trademark of the AstraZeneca group of companies. Registered user AstraZeneca Pty. Ltd. ABN 54 009 682 311. 66 Talavera Road, Macquarie Park, NSW 2113. www.astrazeneca.com.au. For Medical Information enquiries or to report an adverse event or product quality complaint: Telephone 1800 805 342 or via https://contactazmedical.astrazeneca.com. AU-21542, E-017303, January 2025, INDE14102.

Cvent Privacy Policy
Privacy Policy